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Introduction {#sec1}
============

Formation of episodic memory is a multistep brain process that requires activity of the medial temporal lobe ([@bib56]). The hippocampus in particular participates in long-term storage of recently acquired events. Hippocampal circuits are regulated by a large variety of local inhibitory interneurons that are controlled by neuromodulatory systems ensuring their coordinated function to shape behavioral responses ([@bib30]); the identities and functions of the interneurons are under intense scrutiny ([@bib23]; [@bib46]; [@bib45]).

The endocannabinoid system is a brain-modulatory signaling hub formed mainly by type 1 cannabinoid receptors (CB~1~Rs), their endogenous ligands (endocannabinoids), and enzymes for their synthesis and degradation. In the hippocampus, CB~1~Rs are present in principal neurons and astroglial cells ([@bib8]; [@bib44]). However, the largest expression of CB~1~Rs resides in GABAergic interneurons ([@bib37]; [@bib27]), where they modulate local inhibition of hippocampal circuits. Particularly, the largest amount of CB~1~Rs is expressed in cholecystokinin (CCK)-positive interneurons, which are characterized by asynchronous neurotransmitter release ([@bib23]; [@bib28]; [@bib38]).

Hippocampal CB~1~Rs control episodic-like memory processes and synaptic plasticity ([@bib50]; [@bib24]; [@bib47]). However, the specific locations where these receptors participate in the mechanisms underlying hippocampus-dependent memory are only partially known.

Activity-dependent long-term changes in hippocampal synaptic transmission are considered cellular correlates of memory consolidation ([@bib43]; [@bib60]), which involves local dopamine D~1~ receptor (D~1~R) signaling ([@bib36]; [@bib62]). Exposure to hippocampus-dependent behavioral tasks induces changes in long-term potentiation (LTP) of synaptic transmission that require activation of D~1~-like receptors ([@bib18]; [@bib22]; [@bib34]; [@bib33]). A novel subpopulation of hippocampal CB~1~R/CCK-positive interneurons containing D~1~R was recently described ([@bib49]; [@bib19]). However, the potential interactions between D~1~Rs and CB~1~Rs in regulating learning-induced plasticity, activity of hippocampal circuits, and memory processes remain unexplored.

Here we assessed the role of D~1~R/CB~1~R-positive cells in regulation of episodic-like novel object recognition (NOR) memory. We found that conditional deletion of the *CB*~*1*~R gene in hippocampal D~1~R-positive cells impairs long- but not short-term NOR memory and learning-induced LTP enhancement involving local control of GABAergic transmission. These intriguing results suggest that CB~1~R signaling provides a functional link between hippocampal dopaminergic and GABAergic control of synaptic plasticity and memory consolidation.

Results {#sec2}
=======

CB~1~Rs in Hippocampal D~1~R-Positive Neurons Are Necessary for Consolidation of NOR Memory {#sec2.1}
-------------------------------------------------------------------------------------------

Mutant mice bearing a deletion of the *CB*~*1*~R gene in cells expressing D~1~R (D~1~-*CB*~*1*~-knockout \[KO\] mice; [@bib40]) displayed no phenotype in the short-term version (3 h post-training) of a NOR task ([Figures 1](#fig1){ref-type="fig"}A and 1B; [@bib47]; [@bib6]; [@bib50]). Conversely, they showed strong impairment in long-term (24 h) memory compared with their wild-type (WT) littermates ([Figure 1](#fig1){ref-type="fig"}C), with no changes in total exploration time ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1D).Figure 1Hippocampal CB~1~Rs in D~1~R-Positive Cells Are Necessary for Late but Not Early Consolidation of NOR(A) Schematic representation of the NOR memory task.(B) Short-term (3 h) NOR memory performance of D~1~-*CB*~*1*~-WT mice (n = 10) and D~1~-*CB*~*1*~-KO littermates (n = 7).(C) Long-term NOR (24 h) memory performance of D~1~-*CB*~*1*~-WT mice (n = 9) and D~1~-*CB*~*1*~-KO littermates (n = 8).(D) Schematic representation of the experiment using viral re-expression of the *CB*~*1*~R gene in the striatum (STR) or the hippocampus (HPC) of D~1~-*CB*~*1*~-WT mice and D~1~-*CB*~*1*~-KO littermates.(E) Representative images of Cre-expressing D~1~-*CB*~*1*~-KO mice injected with CB~1~R-myc in the STR using the same procedure as described in (D) ([STAR Methods](#sec5){ref-type="sec"}). Scale bar, 2 mm.(F) NOR memory performance of mice with re-expression of the *CB*~*1*~R gene in the STR or HPC. Control, n (D~1~-*CB*~*1*~-WT) = 17 and n (D~1~-*CB*~*1*~-KO) = 5; STR*-CB*~*1*~-RS, n (D~1~-*CB*~*1*~-KO) = 6; HPC-*CB*~*1*~-RS, n (D~1~-*CB*~*1*~-KO) = 9.(G) Immunofluorescence of cells expressing CB~1~R-myc in the HPC. Scale bar, 500 μm.(H) Schematic representation of the experiment using viral expression of the Gi-DREADDs or mCherry in the HPC of D~1~-*CB*~*1*~-WT mice and D~1~-*CB*~*1*~-KO littermates. Clozapine N-oxide (CNO; 2 mg/kg) injections take place after the training phase of the NOR task.(I) NOR memory performance of D~1~-*CB*~*1*~-WT mice injected intra-hippocampally with hM4D(Gi) virus or mCherry (n VEH = 16, n CNO = 21), D~1~-*CB*~*1*~-KO mice injected with mCherry (n VEH = 6, n CNO = 7), and D~1~-*CB*~*1*~-KO mice injected intra-hippocampally with hM4D(Gi) (n VEH = 11, n CNO = 14).Data, mean ± SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001. ns, not significant. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

The majority of CB~1~Rs in D~1~R-positive neurons have been characterized previously in striatonigral circuits ([@bib40]). Considering the involvement of these circuits in NOR memory ([@bib15]), we tested the role of striatal CB~1~Rs. We infused an adeno-associated virus carrying a Cre-dependent expression of CB~1~Rs (pAAV-CAG-DIO-*CB*~*1*~) into the striatum of D~1~-*CB*~*1*~-KO mice to obtain re-expression (RS) of CB~1~Rs in cells where Cre is present (hereafter called D~1~R-positive) in this brain region (striatum \[STR\]-*CB*~*1*~-RS mice; [Figures 1](#fig1){ref-type="fig"}D and 1E), as revealed by immunodetection of a myc-tagged version of CB~1~Rs (CB~1~R-myc; [STAR Methods](#sec5){ref-type="sec"}; [Figure 1](#fig1){ref-type="fig"}E). This re-expression was not sufficient to rescue the phenotype of D~1~-*CB*~*1*~-KO mice in long-term NOR ([Figures 1](#fig1){ref-type="fig"}F, [S1](#mmc1){ref-type="supplementary-material"}E, and S1F), suggesting that CB~1~Rs in striatal D~1~R-positive cells do not participate in this type of memory. Anatomical data indicate that a subset of hippocampal neurons contain D~1~Rs ([@bib19]), likely co-expressing CB~1~R protein ([@bib49]). Thus, we re-express the *CB*~*1*~R gene in the hippocampus of D~1~-*CB*~*1*~-KO mice to obtain hippocampus (HPC)-*CB*~*1*~-RS mice ([Figures 1](#fig1){ref-type="fig"}D and 1G). This manipulation fully rescued the phenotype of the mutant mice ([Figure 1](#fig1){ref-type="fig"}F, [S1](#mmc1){ref-type="supplementary-material"}E, and S1F), indicating that hippocampal CB~1~Rs expressed in D~1~R-positive cells are required for NOR memory.

We recently reported that deletion of CB~1~Rs in hippocampal glial acidic fibrillary protein (GFAP)-positive cells (i.e., mainly astrocytes, GFAP-*CB*~*1*~-KO mice) also impaired NOR memory ([@bib50]). Indeed, GFAP-*CB*~*1*~-KO mice were impaired in NOR ([Figures S1](#mmc1){ref-type="supplementary-material"}G--S1I; [@bib50]), but, in contrast to D~1~-*CB*~*1*~-KO mice, this phenotype extended to short-term NOR memory ([Figures S1](#mmc1){ref-type="supplementary-material"}J--S1L). This difference suggests that CB~1~Rs expressed in hippocampal astrocytes or D~1~R-positive cells might control distinct phases of NOR memory consolidation.

The primary function of CB~1~R activation in neurons is to decrease neurotransmitter release ([@bib13]; [@bib11]). Accordingly, deletion of CB~1~Rs from neurons often results in excessive neurotransmission. Thus, we reasoned that inhibition of hippocampal D~1~R-positive neurons during NOR consolidation should be able to rescue the memory impairment of D~1~-*CB*~*1*~-KO mice. Viral vectors carrying Cre-dependent expression of an inhibitory designer receptor exclusively activated by designer drugs (DIO-hM4DGi, Gi-DREADD; [@bib51]) or control mCherry protein were infused into the hippocampi of D~1~-*CB*~*1*~-KO mice and WT littermates ([Figure 1](#fig1){ref-type="fig"}H). Post-training clozapine N-oxide (CNO) injections did not affect the NOR performance of D~1~-*CB*~*1*~-KO and WT mice injected with Gi-DREADD or mCherry, indicating that the drug or its metabolites had no effect per se ([@bib20]; [Figures 1](#fig1){ref-type="fig"}I, [S1](#mmc1){ref-type="supplementary-material"}M, and S1N). Conversely, post-acquisition CNO treatment fully rescued the NOR impairment of D~1~-*CB*~*1*~-KO mice expressing Gi-DREADD ([Figures 1](#fig1){ref-type="fig"}I, [S1](#mmc1){ref-type="supplementary-material"}M, and S1N). This strongly suggests that excessive activity of D~1~R-positive neurons during the consolidation process is responsible for the memory impairment observed in D~1~-*CB*~*1*~-KO mice.

CB~1~Rs in Hippocampal D~1~R-Positive Neurons Control Learning-Induced Changes of LTP *In Vivo* {#sec2.2}
-----------------------------------------------------------------------------------------------

Cellular and molecular mechanisms underlying activity-dependent changes in synaptic plasticity are proposed to underlie long-term memory ([@bib1]). Previous studies showed that conditional and global deletion of CB~1~Rs in neuronal and glial cell populations induces deficits in learning and associated synaptic plasticity ([@bib11]; [@bib50]). To address the role of CB~1~Rs in hippocampal D~1~R-positive neurons in modulation of synaptic plasticity, we recorded *in-vivo*-evoked field excitatory postsynaptic potentials (fEPSPs) in the hippocampal CA3-CA1 pathway of anesthetized mice. High-frequency stimulation (HFS) induced similar long-lasting LTP of synaptic fEPSPs in D~1~-*CB*~*1*~-KO and WT littermates ([Figures 2](#fig2){ref-type="fig"}A and 2B), indicating that hippocampal D~1~R/CB~1~R-positive neurons are dispensable for expression of LTP in naive animals.Figure 2Learning-Induced Facilitation of *In Vivo* Hippocampal LTP Requires CB~1~Rs at D~1~R-Positive Neurons(A and B) HFS in the dorsal hippocampal CA3 Schaffer collateral pathway induces *in vivo* LTP in the dorsal CA1 *stratum radiatum*.(A) Summary plots of recorded evoked fEPSPs in anesthetized D~1~-*CB*~*1*~-WT (n = 8) and D~1~-*CB*~*1*~-KO (n = 8) mice.(B) Bar histograms of normalized fEPSPs from (A), representing 30 and 60 min after HFS.(C) Schematic representation of the experimental setup ([STAR Methods](#sec5){ref-type="sec"}).(D and E) Learning modulates *in vivo* LTP.(D) Summary plots of recorded evoked fEPSPs from mice exposed to control (n = 8) and NOR training (n = 11) conditions.(E) Bar histograms of normalized of evoked fEPSPs from (D), representing 30 and 60 min after HFS.(F and G) Learning-induced modulation of *in vivo* LTP is impaired in D~1~-*CB*~*1*~-KO mice.(F) Summary plots of recorded fEPSPs in anesthetized D~1~-*CB*~*1*~-WT (n = 10) and D~1~-*CB*~*1*~-KO (n = 10) mice.(G) Bar histograms of normalized of evoked fEPSPs from (F), representing 30 and 60 min after HFS.Traces on the right side of the summary plots represent 150 superimposed evoked fEPSPs before HFS (1, gray) and 30 min (2, brown) and 60 min (3, black) after HFS. Data, mean ± SEM. ^∗^p \< 0.05. See also [Table S1](#mmc1){ref-type="supplementary-material"}.

HPC-dependent memory-related processes such as LTP are sensitive to pharmacological and genetic modulation of hippocampal D~1~Rs, particularly after learning ([@bib34]; [@bib33]; [@bib57]; [@bib62]). Thus, we hypothesized that CB~1~Rs in D~1~R-positive neurons may modulate learning-dependent hippocampal synaptic plasticity. To explore whether acquisition of the NOR task modulates *in vivo* LTP, we recorded fEPSPs from C57Bl6/NRj mice after a NOR task ([Figure 2](#fig2){ref-type="fig"}C). HFS induced stronger LTP in animals exposed to NOR acquisition than in control mice ([Figures 2](#fig2){ref-type="fig"}D and 2E), showing that the training modulates hippocampal synaptic plasticity. Strikingly, D~1~-*CB*~*1*~-KO mice lacked this learning-induced enhancement of LTP ([Figures 2](#fig2){ref-type="fig"}F and 2G). Thus, physiological activation of CB~1~Rs in hippocampal D~1~R-positive neurons is required for learning-dependent facilitation of LTP.

CB~1~R in Hippocampal D~1~R-Positive Neurons Modulate NOR Memory Consolidation through a GABA-Dependent Mechanism {#sec2.3}
-----------------------------------------------------------------------------------------------------------------

D~1~Rs are expressed in different hippocampal cells, including subsets of GABAergic and glutamatergic neurons ([@bib19]). Considering that CB~1~R signaling decreases the activity of hippocampal neurons ([@bib11]; [@bib13]), we asked whether excessive glutamatergic or GABAergic neurotransmission might underlie the phenotype of D~1~-*CB*~*1*~*-*KO mice. Thus, we injected non-amnesic doses ([@bib47]) of the NMDA receptor blocker MK-801, the AMPA/kainate receptor antagonist NBQX ([Figure S2](#mmc1){ref-type="supplementary-material"}A), or the GABA~A~ receptor antagonist bicuculline into D~1~-*CB*~*1*~-KO and WT littermates immediately after NOR training. MK-801 and NBQX did not alter memory performance in WT mice, nor did it rescue the amnesic phenotype of D~1~-*CB*~*1*~-KO littermates ([Figures 3](#fig3){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C). Conversely, bicuculline completely reversed the memory impairment of D~1~-*CB*~*1*~-KO mice when injected immediately after training or 1 h later without affecting WT littermates' performance ([Figures 3](#fig3){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C).Figure 3Hippocampal CB~1~R/D~1~R-Positive Interneurons Modulate Synaptic GABAergic Transmission(A) NOR memory performance of mutant mice administered vehicle (n D~1~-*CB*~*1*~-WT = 14, n D~1~-*CB*~*1*~-KO = 14), MK-801 (0.1 mg/kg, intraperitoneally \[i.p.\]; n D~1~-*CB*~*1*~-WT = 7, n D~1~-*CB*~*1*~-KO = 7), NBQX (5 mg/kg, i.p.; n D~1~-*CB*~*1*~-WT = 8, n D~1~-*CB*~*1*~-KO = 5), or bicuculline immediately after (n D~1~-*CB*~*1*~-WT = 10, n D~1~-*CB*~*1*~-KO = 10) or 1 h after the training phase (n D~1~-*CB*~*1*~-WT = 10, n D~1~-*CB*~*1*~-KO = 8).(B) Schematic representation of the experimental procedure to detect *CB*~*1*~R mRNA in D~1~R-positive cells.(C and D) Representative images of CB~1~R mRNA (green) and mCherry protein (red) labeling in the hippocampal CA1 region of D~1~-Cre (C) and D~1~-*CB*~*1*~-KO (D) mice. White arrows indicate colocalization of CB~1~R-positive and D~1~R-positive cell bodies. Scale bar, 150 μm.(E and F) Layer-specific distribution of the percentage of cell bodies expressing high (E) and low amounts (F) of CB~1~Rs, which colocalize with mCherry-positive (i.e., D~1~R-positive) in D~1~-Cre (n = 3) and D~1~-*CB*~*1*~-KO (n = 3).Data, mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01. See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

These data indicate that excessive GABAergic but not glutamatergic ionotropic receptor activity is involved in the phenotype of D~1~-*CB*~*1*~-KO mice. A large proportion of GABAergic hippocampal interneurons contain CB~1~R mRNA, which is expressed at different levels (high CB~1~R- and low CB~1~R-expressing cells; [@bib38]). Conversely, D~1~R mRNA is expressed at very low levels in the HPC (<http://mouse.brain-map.org/experiment/show/35>; data not shown), which makes it difficult to accurately quantify its expression above background. Therefore, to pinpoint which CB~1~R-positive interneurons in the HPC contain D~1~R, we combined fluorescence *in situ* hybridization for CB~1~R mRNA in D~1~-Cre and D~1~-*CB*~*1*~-KO mice carrying viral Cre-dependent expression of mCherry ([STAR Methods](#sec5){ref-type="sec"}; [Figure 3](#fig3){ref-type="fig"}B). As described ([@bib38]), detectable levels of CB~1~R mRNA were present throughout the HPC in pyramidal neurons and in GABAergic interneurons ([Figure S2](#mmc1){ref-type="supplementary-material"}D). The distribution of mCherry-tagged D~1~-positive neurons in the dorsal CA1 region of D~1~-Cre mice was similar to previous findings ([@bib49]; [@bib19]). Double staining revealed that virtually no high CB~1~R-expressing interneurons in the *strata oriens*, *pyramidale*, *radiatum*, or *lacunosum moleculare* contain D~1~Rs ([Figures 3](#fig3){ref-type="fig"}C--3F and [S2](#mmc1){ref-type="supplementary-material"}D). Conversely, D~1~Rs are present in a small subpopulation of low CB~1~R-expressing interneurons along the different hippocampal layers ([Figures 3](#fig3){ref-type="fig"}C and 3F). Importantly, this co-expression was virtually abolished in hippocampi of D~1~-*CB*~*1*~-KO mice ([Figures 3](#fig3){ref-type="fig"}C, 3D, and 3F).

Altogether, these data indicate that CB~1~R-dependent modulation of a small subpopulation of D~1~R-positive GABAergic interneurons is required during NOR memory consolidation.

Synaptic Mechanisms Underlying NOR Memory Consolidation and Associated Hippocampal Plasticity {#sec2.4}
---------------------------------------------------------------------------------------------

The data collected so far show that reduction of GABAergic signaling prevents the deficits in D~1~-*CB*~*1*~-KO mice of NOR consolidation. Therefore, we tested whether inhibition of GABA~A~ receptors could rescue the lack of learning-induced LTP enhancement observed in D~1~-*CB*~*1*~-KO mice. Trained mice received bicuculline or vehicle (VEH) before testing LTP induction in hippocampal circuits. In vehicle-treated animals, D~1~-*CB*~*1*~-KO mice showed no training-induced LTP enhancement ([Figures 4](#fig4){ref-type="fig"}A--4C). Strikingly, although bicuculline did not affect LTP in WT animals, it rescued the training-induced LTP of D~1~-*CB*~*1*~-KO mice ([Figures 4](#fig4){ref-type="fig"}A--4C).Figure 4Cellular Mechanisms Linking D~1~R Signaling with GABAergic Activity during Learning-Induced Facilitation of *In Vivo* LTP and Memory Consolidation(A) Effects of the GABA~A~ receptor antagonist bicuculline and the D~1/5~R antagonist SCH-23390 on learning-induced modulation of *in vivo* LTP in D~1~-*CB*~*1*~-WT and D~1~-*CB*~*1*~-KO mice. Shown are summary plots of recorded evoked fEPSPs in vehicle (n D~1~-*CB*~*1*~-WT = 6, n D~1~-*CB*~*1*~-KO = 8), bicuculline (0.5 mg/kg, i.p.; n D~1~-*CB*~*1*~-WT = 9, n D~1~-*CB*~*1*~-KO = 11), and SCH-23390 (0.3 mg/kg, i.p.; n D~1~-*CB*~*1*~-WT = 6, n D~1~-*CB*~*1*~-KO = 6).(B and C) Bar histograms of (A), representing normalized fEPSPs from 30 (B) and 60 (C) min after HFS.(D) Memory performance D~1~-*CB*~*1*~-WT and D~1~-*CB*~*1*~-KO mice after being injected with vehicle (n D~1~-*CB*~*1*~-WT = 6, n D~1~-*CB*~*1*~-KO = 10) or SCH-23390 (0.3 mg/kg, i.p.; n D~1~-*CB*~*1*~-WT = 10, n D~1~-*CB*~*1*~-KO = 10).Traces on the right side of the summary plot (A) represent 150 superimposed evoked fEPSPs before HFS (1, gray) and 30 min (2, brown) and 60 min (3, black) after HFS. Data, mean ± SEM. ^∗^p \< 0.05, ^∗∗^p \< 0.01.See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

Recent data suggest that hippocampal D~1~R-like receptors participate in memory formation, but little is known concerning the cell types involved ([@bib36]; [@bib62]). Our data indicate that CB~1~R-dependent control of GABAergic transmission from a low number of hippocampal interneurons expressing D~1~R is required to guarantee late consolidation of NOR memory. Therefore, it is possible that endocannabinoid actions are secondary to activation of D~1~Rs in these cells. To address this issue, we first reasoned that partial inhibition of D~1~Rs should "replace" the lack of CB~1~R-dependent control of neurotransmission in D~1~-*CB*~*1*~-KO mice. Thus, we administered a sub-effective dose of the D~1/5~R antagonist SCH-23390 ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C) to D~1~-*CB*~*1*~-KO mice and WT littermates after NOR acquisition and analyzed the training-induced enhancement of *in vivo* LTP. This treatment slightly reduced the late phase of LTP in WT animals ([Figures 4](#fig4){ref-type="fig"}A--4C). However, the antagonist abolished the differences between D~1~-*CB*~*1*~-KO mice and WT littermates ([Figures 4](#fig4){ref-type="fig"}A--4C), indicating that reducing D~1~R activity counteracts the absence of CB~1~Rs in the mutants. If LTP is mechanistically linked to NOR consolidation, then the same treatment should rescue the memory impairment of D~1~-*CB*~*1*~-KO mice. Administration of SCH-23390 did not alter the behavior of WT mice ([Figures 4](#fig4){ref-type="fig"}D, [S3](#mmc1){ref-type="supplementary-material"}D, and S3E), but, strikingly, it fully rescued the memory impairment of D~1~-*CB*~*1*~-KO littermates ([Figures 4](#fig4){ref-type="fig"}D, [S3](#mmc1){ref-type="supplementary-material"}D, and S3E).

Altogether, these results indicate that endocannabinoid-dependent regulation of hippocampal D~1~R-positive interneurons is a necessary step in dopaminergic control of NOR memory consolidation and associated synaptic plasticity.

Discussion {#sec3}
==========

The present study reveals that a specific subpopulation of hippocampal D~1~R/CB~1~R-positive neurons controls late consolidation of NOR memory and associated synaptic plasticity by moderating local inhibitory GABAergic activity in the HPC. Specifically, CB~1~Rs expressed in D~1~R-positive interneurons participate in learning-induced facilitation of *in vivo* LTP and are required for consolidation of NOR memory. Moreover, CB~1~Rs in D~1~R-positive neurons are necessary for physiological D~1~R-dependent modulation of memory processes, suggesting that cannabinoid signaling is part of a complex modulatory circuit regulated by dopamine transmission in the HPC. By determining cellular and behavioral functions of a specific CB~1~R-expressing interneuron subpopulation, these data uncover an unforeseen role of CB~1~Rs in the D~1~R-dependent control of long-term memory.

The endocannabinoid system regulates episodic-like recognition memory processes via CB~1~R-dependent control of different cell types in the HPC ([@bib11]; [@bib55]; [@bib10]; [@bib47]; [@bib50]). In the present study, we observed that the transition from short- to long-term memory processes is controlled by a functional interaction between D~1~Rs and CB~1~Rs in a specific subpopulation of hippocampal interneurons. In contrast, CB~1~R deletion from all body cells or in all forebrain GABAergic neurons does not reproduce the phenotype of D~1~-*CB*~*1*~-KO mice ([@bib47]; [@bib24]). These apparently contrasting observations can be explained by different possibilities. Long-term deletion of the *CB*~*1*~R gene starting from early developmental stages in *CB*~*1*~-KO and GABA-*CB*~*1*~-KO mice might induce compensatory mechanisms ([@bib17]; [@bib16]), masking the functional role of the CB~1~R in NOR memory. An alternative or complementary explanation might point to the presence of different subpopulations of brain cells expressing CB~1~Rs and exerting opposite effects on memory processes. For instance, endocannabinoid signaling might promote or inhibit memory formation when acting at D~1~R-positive cells or at other neuronal subpopulations, respectively. We have shown previously that astroglial CB~1~Rs are necessary for consolidation of NOR memory by allowing D-serine availability at glutamatergic synapses ([@bib50]). We cannot fully exclude that deletion of CB~1~Rs in D~1~R-positive cells does not also involve astrocytes ([@bib42]). However, so far, no conclusive anatomical evidence has been presented for expression of D~1~Rs in hippocampal astrocytes ([@bib14]; [@bib64]; but see [@bib25] for D~1/5~R pharmacological experiments). Moreover, our current and past results suggest that endocannabinoid control of astrocytes is likely involved in the initial phases of memory formation, whereas CB~1~R-dependent inhibition of D~1~R-positive hippocampal interneurons determines later phases of NOR memory consolidation. The time-course effects of pharmacological treatments indicate that D-serine can rescue memory performance of GFAP-*CB*~*1*~-KO mice only when administered immediately after learning ([@bib50]). This idea is reinforced by the fact that these mutants do not express *in vivo* LTP even under basal "home cage" conditions ([@bib50]), whereas D~1~-*CB*~*1*~-KO mice only lack the specific facilitation of LTP induced by learning. Altogether, these observations allow speculation that at least two distinct temporal windows exist in CB~1~R-dependent control of NOR. First, astroglial CB~1~R are necessary for the plastic processes to initiate the memory. Later, endocannabinoid-dependent regulation of D~1~R-positive interneurons is required to maintain the memory trace for longer periods.

Hippocampal D~1~R have been shown previously to be mainly on GABAergic interneurons, but lower levels were also detected on glutamatergic neurons ([@bib19]; [@bib49]; <http://celltypes.brain-map.org/rnaseq/mouse_ctx-hip_smart-seq>). Our data show that the D~1~-Cre mouse line used in the present study ([@bib32]) induces recombination in a small sub-fraction of hippocampal interneurons containing low levels of CB~1~R mRNA but also in pyramidal neurons and mossy cells. Therefore, we cannot fully exclude that cell types other than hippocampal interneurons might participate in D~1~R/CB~1~R-dependent control of memory consolidation. However, our data show that partial blockade of GABA~A~ receptors, but not of AMPA/kainate or NMDA glutamatergic ones, reverse the memory impairment of D~1~-*CB*~*1*~-KO mice. Therefore, our findings strongly suggest that CB~1~R control of GABA release from D~1~R-positive interneurons regulates late consolidation of NOR memory. However, recent data using emerging technologies suggest that hippocampal cells are more diverse and functionally segregated than previously thought ([@bib23]; [@bib54]). By identifying specific markers, future studies will extend our genetic and pharmacological evidence that a specific subpopulation of D~1~R/CB~1~R-positive hippocampal interneurons regulates consolidation of NOR memory.

LTP at the CA3-CA1 pathway is a potential molecular and cellular mechanism underlying behavioral expression of episodic-like memory processes ([@bib41]). Interestingly, although deletion of CB~1~Rs from D~1~R-positive cells impairs NOR memory, the same manipulation does not impair *in vivo* LTP of hippocampal synaptic transmission in naive animals. In agreement with previous evidence under other experimental conditions ([@bib34]; [@bib33]), WT mice exposed to the NOR learning task display facilitation of *in vivo* LTP compared with animals exposed to the same environment without any learning. Importantly, this facilitation is absent in D~1~-*CB*~*1*~-KO mice, suggesting that endocannabinoid control of D~1~R-positive hippocampal interneurons is recruited only after learning. The facilitation might be due to "real" stronger synaptic transmission after learning or a decrease in baseline synaptic activity ([@bib35]), which might be occluded in D~1~-*CB*~*1*~-KO mice. The fact that partial blockade of GABA~A~ receptors in trained WT mice does not alter LTP facilitation suggests that this phenomenon is due to a genuine increase in LTP. In addition, our data indicate that reducing GABAergic transmission in D~1~R-positive neurons is required for this form of learning-induced synaptic plasticity. These results reinforce the idea that, to reveal relevant mechanisms, investigations of synaptic plasticity associated with memory processes should include not only naive animals but also behaviorally challenged ones ([@bib36]).

D~1~R activity in the HPC is necessary for long-term memory, synaptic plasticity, and network dynamics ([@bib36]; [@bib62]; [@bib29]; [@bib5]). Consistently, our results show that high doses of the D~1/5~R antagonist SCH-23390 impair memory performance in the NOR task. In addition, our data suggest that D~1~R/CB~1~R-positive hippocampal interneurons are one of the targets of dopaminergic control of learning and memory processes. Interestingly, it has been shown that parvalbumin (PV)-expressing interneurons require D~1~R activity for late phases of memory consolidation through coordinated control of the activity of hippocampal pyramidal neurons ([@bib26]). Particularly, the authors describe that this D~1~R activity modulates hippocampal network oscillations (i.e., sharp-wave ripples), which is a proposed correlate for synaptic plasticity and memory consolidation ([@bib12]). In addition, previous studies have shown that PV/CB~1~R-negative and CCK/CB~1~R-positive interneurons have complementary roles in ensuring such high oscillatory ripple events with consequent capacity to modulate synaptic plasticity ([@bib31]; [@bib12]). Therefore, we speculate that the subpopulation of D~1~R/CB~1~R-positive interneurons described in our work could play a complementary role in maintaining a proper excitation/inhibition balance in the hippocampal network activity required for memory consolidation.

Although complete elucidation of the complex microcircuitry requires further characterization, our findings support the hypothesis that D~1~R/CB~1~R-positive hippocampal interneurons belong to a broader circuit participating in dopaminergic control of memory ([@bib62]). Our data are compatible with a scenario where D~1~R activation during the learning/consolidation process potentiates GABAergic transmission. However, this D~1~R-dependent increase in inhibition is kept within adequate limits by activation of CB~1~Rs, allowing proper flow of information. In this sense, in the absence of CB~1~R-dependent control of D~1~R/CB~1~R-positive interneurons (i.e., D~1~-*CB*~*1*~-KO mice), partial inhibition of D~1~-like or GABA~A~ receptors rescues the phenotype. In other words, although activation of D~1~Rs in interneurons seems to be necessary for the memory process, their abnormally high activity (*e.g*. in the absence of CB~1~Rs) impairs such functions. In this context, an interesting question relates to the functional link between endogenous activation of D~1~Rs and CB~1~Rs. Our results allow speculation about two potential scenarios based on autocrine or paracrine modes of action of endocannabinoid signaling ([@bib11]). (1) General D~1~R-dependent dopaminergic signaling in the HPC might activate pyramidal neurons ([@bib52]; [@bib53]) targeted by D~1~R/CB~1~R-positive interneurons. This depolarization of pyramidal neurons would, in turn, induce canonical endocannabinoid-dependent retrograde inhibition of GABAergic release ([@bib13]), moderating, among others, activation of D~1~R/CB~1~R-positive interneurons. (2) Following D~1~R activation and consequent interneuron depolarization ([@bib2]; [@bib21]), endocannabinoids might be mobilized locally and act in an autocrine manner to decrease the membrane potential and thereby moderate the activity of the neuron ([@bib4]). These two possibilities are not mutually exclusive, and they might reflect the effect of the mechanisms described on general network activity and/or on specific plastic cellular processes, respectively. Future studies will investigate these intriguing scenarios using adapted experimental approaches.

Altogether, these data reveal that functionally distinct cell types are present in the general population of hippocampal GABAergic interneurons expressing CB~1~Rs. In particular, D~1~R/CB~1~R-positive interneurons provide specific behavioral and hippocampal synaptic mechanisms sustaining the fine-tuned regulation of memory processes. The close interaction of CB~1~Rs and D~1~Rs in modulating recognition memory might provide novel therapeutic frameworks for treatment of cognitive diseases characterized by alterations of endocannabinoid or dopaminergic systems or both.
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REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit antibody against the C-myc epitope tagBioLegendCat\# 906301; RRID:[AB_2565064](nif-antibody:AB_2565064){#interref35}Goat anti-rabbit antibody Alexa Fluor 488Fisher ScientificCat\# A-11008; RRID:[AB_143165](nif-antibody:AB_143165){#interref40}4',6-diamidino-2-phenylindoleFisher ScientificCat\# D3571; RRID:[AB_2307445](nif-antibody:AB_2307445){#interref45}Rabbit polyclonal antibody against DsRedTakara BioCat\# 632496; RRID:[AB_10013483](nif-antibody:AB_10013483){#interref50}Secondary antibody goat anti-rabbit conjugated to a horseradish peroxidaseCell signalingCat\#7074S; RRID:[AB_2099233](nif-antibody:AB_2099233){#interref55}Digoxigenin (DIG)-labeled riboprobe against mouse CB~1~[@bib38]N/AAnti-DIG antibody conjugated to HRPRocheCat\#11207733910; RRID:[AB_514500](nif-antibody:AB_514500){#interref60}**Bacterial and Virus Strains**rAAV-CAG-DIOLead contact labrAAV-30AAV-CAG-DIO-*CB*~*1*~Lead contact labrAAV-37AAV-CAG-DIO-*CB*~*1*~*-myc*Lead contact labrAAV-21hSyn-DIO-hM4D(Gi)-mCherryAddgene44361-AAV8pAAV-hSyn-DIO-mCherryAddgene50459-AAV8**Chemicals, Peptides, and Recombinant Proteins**2-methylbutaneSigma-AldrichM32631-1LTSA plus fluorescein systemPerkin ElmerNEL741001KTStreptavidin-Texas RedPerkin ElmerNEL721001EANormal donkey serumMerckS30-100MLSheep SerumSigma AldrichS3772-10MLFormaldehyde 4%Sigma AldrichHT501128-4LBlocking reagent (to prepare NEN)Perkin ElmerFP1012TSA Biotin SystemsPerkin ElmerNEL700A001KTSSC 20XSigma93017-10L-FFluoromount-GSlide Mounting MediumElectron microscopy sciences17984-25IsofluraneVirbacVnr137317BicuculineSigma-Aldrich14343-50MGSCH 23390Sigma-AldrichD054-10MGMK-801Sigma-Aldrich77086-22-7clozapine-N-oxide CNOTocris4936**Critical Commercial Assays**Avidin/Biotin Blocking KitVector LabsSP-2001**Experimental Models: Organisms/Strains**D~1~-*CB*~*1*~-WT and D~1~-*CB*~*1*~-KOLead contact labN/AC57BL/6NJanvier LabsC57BL/6NRjD~1~-CreLead contact labTg(Drd1a-cre)AGsc/KndlJ,CB~1~^*flox/flox*^Lead contact labCnr1tm1.2Ltz, MGI:[3045419](mgi:3045419){#intref0020}GFAP-*CB*~*1*~-WT and GFAP-*CB*~*1*~-KOLead contact labN/A**Software and Algorithms**PrismGraphpad SoftwareV6.0CED 1401 Spike2Cambridge Electronic DesignV6.18ImageJNIHV1.52
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### Lead Contact {#sec5.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Giovanni Marsicano (<giovanni.marsicano@inserm.fr>).

### Materials Availability {#sec5.2.2}

Mouse lines generated and used in the current study are available from the lead contact upon request. We are glad to share the mouse lines with reasonable compensation by requestor for its processing and shipping.

### Data and Code Availability {#sec5.2.3}

The data supporting the current study have not been deposited in a public repository but are available from the lead contact on request.

Experimental Model and Subject Details {#sec5.3}
--------------------------------------

### Animal Model {#sec5.3.1}

All experimental procedures were approved by the ethical committee of the French Ministry of Higher Education, Research and Innovation (authorization APAFIS\#18111). Maximal efforts were made to reduce the suffering of the animals. Male mice were used in this study.

D~1~-*CB*~*1*~-KO mice were generated as previously described ([@bib40]; [@bib59]). Briefly, CB~1~ floxed mice ([@bib39]) were crossed with D~1~-Cre line ([@bib32]), in which the Cre recombinase was placed under the control of the D~1~ gene (Drd1a) regulatory sequences using transgenesis with modified bacterial artificial chromosomes. The pattern of Cre expression recapitulated the expression pattern of the endogenous Drd1a ([@bib32]). Breeding was performed by mating male Cre-positive D~1~-*CB*~*1*~-KO mice with homozygous *CB*~*1*~-flox female mice deriving from a separate colony. In order to detect possible germline or ectopic recombination events, genotyping of tail samples from pups (PD10) was performed by genomic PCR using primers suited to identify WT, "floxed" and "recombined" bands. No germline or ectopic recombination was detected. Eight to 14 weeks-old naive male D~1~-*CB*~*1*~-KO and WT littermates were used. 8-14 weeks old male C57BL/6NRj mice purchased from Janvier (France). 8-12 weeks-old D~1~-Cre mice breed in the animal facilities of the U1215 we also used. Animals were housed collectively under standard conditions of temperature and humidity in a day/night cycle of 12/12 hours (light on at 7 am). Animals that underwent surgery were kept in individual cages after the procedures to avoid conflict with their littermates. Food and water were provided *ad libitum*. All the experiments were performed during the light phase. Behavioral experiments were performed from 9 am to 3 pm. Electrophysiology experiments were performed from 8 am to 7 pm.

Method Details {#sec5.4}
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### Drug preparation and administration {#sec5.4.1}

Bicuculline, MK-801, NBQX and SCH-23390 were purchased from Merck (formerly Sigma-Aldrich, France) and were dissolved to their final concentration in physiological saline (NaCl 0.9%). The exogenous DREADD ligand clozapine-N-oxide (CNO, 2 mg/kg) was purchased from Tocris Bioscience (Bristol, UK) and dissolved in saline after gently mixing with a vortex. All drugs were injected intraperitoneally in a volume of 10 ml/kg. Vehicle in all the conditions was composed of physiological saline (NaCl 0.9%) injections.

### Novel object recognition memory {#sec5.4.2}

We used the novel object recognition (NOR) memory task in an L-maze ([@bib6], [@bib7]; [@bib24]; [@bib47], [@bib48]; [@bib50]).

The task took place in a L-shaped maze made of dark gray polyvinyl chloride made by two identical perpendicular arms (35 cm and 30 cm long respectively for external and internal L walls, 4.5cm wide and 15 cm high walls) placed on a white background ([@bib6]; [@bib47]). The task occurred in a room adjacent to the animal house with a light intensity fixed at 50 lux. The maze was overhung by a video camera allowing the detection and offline scoring of animal's behavior. The task consisted in 3 sequential daily trials of 9 minutes each. During the habituation phase (day 1), mice were placed in the center of the maze and allowed to freely explore the arms in the absence of any objects. The training phase (day 2) consisted in placing the mice again in the corner of the maze in the presence of two identical objects positioned at the extremities of each arm and left to freely explore the maze and the objects. The testing phase occurred 24 hours later (day 3): one of the familiar objects was replaced by a novel object different in its shape, color and texture and mice were left to explore both objects. The position of the novel object and the associations of novel and familiar were randomized. All objects were previously tested to avoid biased preference. Memory performance was assessed by the discrimination index (DI). The DI was calculated as the difference between the time spent exploring the novel (TN) and the familiar object (TF) divided by the total exploration time (TN+TF): DI = \[TN-TF\]/\[TN+TF\]. Memory was also evaluated by directly comparing the exploration time of novel and familiar objects, respectively. Object exploration was defined as the orientation of the nose to the object at less than 2 cm. Experienced investigators evaluating the exploration were blind of treatment and/or genotype of the animals. Pharmacological treatments were immediately administered after the training phase.

### *In vivo* electrophysiology in anesthetized mice {#sec5.4.3}

Experiments were performed as described in [@bib50]. Mice were anesthetized in a box containing 5% Isoflurane (Virbac, France) before being placed in a stereotaxic frame (Model 900, Kopf instruments, CA, USA) in which 1.0% to 1.5% of Isoflurane was continuously supplied via an anesthetic mask during the whole duration of the experiment. The body temperature was maintained at ± 36.5°C using a homeothermic system (model 50-7087-F, Harvard Apparatus, MA, USA) and the state of anesthesia was assessed by mild tail pinch. Before surgery, 100 mL of the local anesthetic lurocaine (vetoquinol, France) was injected in the scalp region. Surgical procedure started with a longitudinal incision of 1.5 cm in length aimed to expose Bregma and Lambda. After ensuring the correct alignment of the head, two holes were drilled in the skull for electrode placement. Glass recording electrodes were inserted in the CA1 stratum radiatum, and a concentric stimulating bipolar electrode (Model CBARC50, FHC, ME, USA) placed in the CA3 region. Coordinates were as follows: CA1 stratum radiatum: A/P 1.5, M/L 1.0, DV 1.20; CA3: A/P 2.2, M/L 2.8, D/V 1.3 (20 insertion angle). The recording electrode (tip diameter = 1--2 mm, 2-4 MΩ) was filled with a 2% pontamine sky blue solution in 0.5M sodium acetate. At first the recording electrode was placed by hand until it reached the surface of the brain and then to the final depth using a hydraulic micropositioner (Model 2650, KOPF instruments, CA, USA). The stimulation electrode was placed in the correct area using a standard manipulator. Both electrodes were adjusted to find the area with maximum response. *In vivo* recordings of evoked field excitatory postsynaptic potentials (fEPSPs) were amplified 1000 times and filtered (low-pass at 1Hz and high-pass 3000Hz) by a DAGAN 2400A amplifier (DAGAN Corporation, MN, USA). fEPSPs were digitized and collected on-line using a laboratory interface and software (CED 1401, SPIKE 2; Cambridge Electronic Design, Cambridge, UK). Test pulses were generated through an Isolated Constant Current Stimulator (DS3, Digitimer, Hertfordshire, UK) triggered by the SPIKE 2 output sequencer via CED 1401 and collected every 2 s at a 10 kHz sampling frequency and then averaged every 180 s. Test pulse intensities were typically between 40-250 μA with a duration of 50 ms. Basal stimulation intensity was adjusted to 30%--50% of the current intensity that evoked a maximum field response. All responses were expressed as percent from the average responses recorded during the 15 min before high frequency stimulation (HFS). HFS was induced by applying 3 trains of 100 Hz (1 s each), separated by 20 s interval. fEPSP were then recorded for a period of 60 min. C57BL6/NRj mice underwent this *in vivo* electrophysiology procedure after the training phase of NOR task. Also, where specified, D~1~-*CB*~*1*~-KO and D~1~-*CB*~*1*~-WT received an injection of Bicuculine (0.5 mg/kg, intraperitoneal) or SCH 23390 (0.3 mg/kg, intraperitoneal) or vehicle immediately after undergoing training in NORT and before being subjected to the *in vivo* electrophysiology procedure. At the end the experiment, the position of the electrodes was marked (recording area: iontophoretic infusion of the recording solution during 180 s at 20mA; stimulation area: continuous current discharge over 20 s at +20mA) and histological verification was performed *ex vivo*.

### Surgery and viral administration {#sec5.4.4}

Mice were anesthetized in a box containing 5% Isoflurane (Virbac, France) before being placed in a stereotaxic frame (Model 900, Kopf instruments, CA, USA) in which 1.0% to 1.5% of Isoflurane was continuously supplied via an anesthetic mask during the whole duration of the experiment. For viral intra-HPC AAV delivery, mice were submitted to stereotaxic surgery (as above) and AAV vectors were injected with the help of a microsyringe (0.25 mL Hamilton syringe with a 30-gauge beveled needle) attached to a pump (UMP3-1, World Precision Instruments, FL, USA). Where specified, D~1~-*CB*~*1*~-WT and D~1~-*CB*~*1*~-KO mice were injected directly into the hippocampus (HPC) or striatum (STR) (0.5 μl per injection site at a rate of 0.5 μl per min), with the following coordinates: HPC, AP −1.8; ML ± 1; DV −2.0 and −1.5; Striatum: AP −1.34; ML ± 2.8; DV −1.84. Following virus delivery, the syringe was left in place for 1 minute before being slowly withdrawn from the brain. CB~1~ *floxed* mice were injected with rAAV-CAG-DIO (empty control vector), AAV-CAG-DIO-*CB*~*1*~ or AAV-CAG-DIO-CB~1~-myc to induce re-expression of the CB~1~ receptor gene in hippocampal or striatal D~1~-positive cells. To generate the aforementioned rAAVs, mouse *CB*~*1*~ receptor coding sequence (either native or fused to myc-tag at the C term) was cloned in rAAV-CAG-DIO vector using standard molecular cloning technology. The coding sequence was cloned inverted in orientation to allow Cre-dependent expression of CB~1~ receptors ([@bib3]). In another experiment, and using the same procedure as described as above, D~1~-*CB*~*1*~-WT and D~1~-*CB*~*1*~-KO mice were injected intra hippocampally (AP −1.8; ML ± 1; DV −2.0 and −1.5), with pAAV-hSyn-DIO-hM4D(Gi)-mCherry or pAAV-hSyn-DIO-mCherry (addgene, USA). For anatomical experiments and using the same procedure as above, D~1~-Cre and D~1~-*CB*~*1*~-KO were injected intra hippocampally with pAAV-hSyn-DIO-mCherry. In this specific experiment, expression was allowed to take place for 2 weeks. For the remaining experiments, animals were used around 4-5 weeks after local infusions. Mice were weighed daily and individuals that failed to regain the pre-surgery body weight were excluded from the following experiments.

### Immunohistochemistry on free-floating sections {#sec5.4.5}

Mice were anesthetized with pentobarbital (Exagon, Axience SAS, 400 mg/kg body weight), transcardially perfused with phosphate-buffered solution (PBS 0.1M, pH 7.4) before being fixed with 4% formaldehyde (Sigma-Aldrich). The The brains were extracted and incubated overnight at 4°C in the same fixative, then embedded with sucrose 30% for 3 days and finally frozen in 2-methylbutane (Sigma-Aldrich) at −80°C. Free-floating frozen coronal sections (40 μm) were cut out with a cryostat (Microm HM 500M Microm Microtech), collected collected in an antifreeze solution and conserved at −20°C. Sections were permeabilized in a blocking solution (in PBS: 10% donkey serum, 0.3% Triton X-100) for 1 hour at room temperature (RT). Then, sections were incubated with a rabbit primary antibody against the C-myc epitope tag (1:1000, BioLegend) overnight at 4°C. After several washes with PBS, slices were incubated for 2 hours with a secondary antibody goat anti-rabbit Alexa Fluor 488 (1:500, Fisher Scientific) and then washed in PBS at RT. Finally, sections were incubated with 4',6-diamidino-2-phenylindole (DAPI 1:20000, Fisher Scientific) diluted in PBS for 5 minutes to visualize cell nuclei and then were washed, mounted and coverslipped. All the antibodies were diluted in blocking solution. The sections were imagedimaged with a slides scanner Hamamatsu Nanozoomer 2.0 HT.

### Combined Fluorescent *in situ* hybridization (FISH)/ Immunohistochemistry (IHC) on free-floating frozen sections {#sec5.4.6}

Mice were anesthetized with pentobarbital (Exagon, Axience SAS, 400 mg/kg body weight), transcardially perfused with PBS (0.1M, pH 7.4) before being fixed with 4% formaldehyde (Sigma-Aldrich). The brains were extracted and incubated overnight at 4°C in the same fixative, then embedded with sucrose 30% for 3 days and finally frozen in 2-methylbutane (Sigma-Aldrich) at −80°C. Free-floating frozen coronal sections were cut out with a cryostat (30 μm, Microm HM 500M Microm Microtech) and collected in an antifreeze solution and conserved at −20°C.

Section were washed several times with PBS with diethyl pyrocarbonate (PBS-DEPC) to wash out the antifreeze solution. The endogenous peroxidases were inactivated by incubating the free-floating sections with 3% H~2~O~2~ in PBS-DEPC for 30 minutes. All endogenous biotin, biotin receptors, and avidin binding sites present in the tissue were blocked by using the Avidin/Biotin Blocking Kit (Vector Labs, USA). Then, the slices were incubated overnight at RT with a rabbit polyclonal primary antibody against DsRed (1:1000, Takara Bio) diluted in a blocking solution (0.3% Triton X-100 diluted in PBS-DEPC). The following day, after several washes, the sections were incubated with a secondary antibody goat anti-rabbit conjugated to a horseradish peroxidase (HRP) (1:500, Cell Signaling Technology) during 2 hours at RT followed by TSA Biotin System (Biotin TSA 1:100, PerkinElmer) for 10 minutes at RT. After several washes, the slices were fixed with 4% of formaldehyde (Sigma Aldrich) for 10 minutes and blocked with 0.2M HCl for 20 minutes at RT. Then, the section were acetylated in 0.1 M Triethanolamine, 0.25% Acetic Anhydride for 10 minutes. This step was performed to reduce non-specific probe binding. Sections were hybridized overnight at 60°C with Digoxigenin (DIG)-labeled riboprobe against mouse CB~1~ receptor (1:1000, prepared as described in [@bib38]). After hybridization, the slices were washed with different stringency wash buffers at 65°C. Then, the sections were incubated with 3% of H~2~O~2~ for 30 minutes at RT and blocked 1 hour with NEN blocking buffer prepared according to the manufacturer's protocol (PerkinElmer). Anti-DIG antibody conjugated to HRP (1:2000, Roche) was applied for 2 hours at RT. The signal of CB~1~ receptor hybridization was revealed by a TSA reaction using fluorescein isothiocyanate (FITC)-labeled tyramide (1:80 for 12 minutes, Perkin Elmer). After several washes, the free-floating slices were incubated overnight at 4°C with Streptavidin-Texas Red (1:400, PerkinElmer). Finally, the slices were incubated with DAPI (1:20000; Fisher Scientific) diluted in PBS, following by several washes, to finally be mounted, coverslipped and imaged with an epifluorescence Leica DM 6000 microscope (Leica, Germany).

Quantification and Statistical Analysis {#sec5.5}
---------------------------------------

### Data collection {#sec5.5.1}

No statistical methods were used to pre-determine sample sizes, but they are similar to those reported in previous publications. All data collection and/or analysis were performed blind to the conditions of the experimenter except for the *in vivo* electrophysiological experiments. All mice were assigned randomly to the different experimental conditions.

### Fluorescence quantifications {#sec5.5.2}

Cells expressing mRNAs were quantified in the different layers (*stratum oriens*, *stratum pyramidale*, *stratum radiatum* and stratum *lacunosum moleculare*) of the dorsal hippocampus. CB~1~ receptor positive cells were classified according to the level of transcript visualized by the intensity of fluorescence ([@bib38]; [@bib58]). ''High-CB~1~'' cells were considered to be round-shaped and intense staining covering the entire nucleus whereas ''Low-CB~1~'' cells were defined with discontinuous shape and lowest intensity of fluorescence allowing the discrimination of grains of staining.

### Statistical analyses {#sec5.5.3}

Data were expressed as mean ± SEM or single data points and were analyzed with Prism 6.0 (Graphpad Software), using two-tails t test (paired, unpaired) or one-way ANOVA (Dunnett's), two-way ANOVA (sidak's). Sample sizes and p values can be found in figure legends and [Table S1](#mmc1){ref-type="supplementary-material"}.
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